BMN 111-302: A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia

Project: Research project

Project Details

StatusActive
Effective start/end date12/18/18 → 8/31/50

Funding

  • BioMarin Pharmaceutical Inc.